The role of genomic oxidative-reductive balance as predictor of complex regional pain syndrome development: A novel theory

Pain Physician

Volumn 13, Issue 1, 2010, Pages 79-90

  Smith, Howard S ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Antioxidant; ARE; Complex regional pain syndrome (CRPS); Nf B; NQO1; Nrf2; Oxidative stress; Single nucleotide polymorphism (SNPs)

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; ACETYLCYSTEINE; ASCORBIC ACID; DIMETHYL SULFOXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLACEBO; TRANSCRIPTION FACTOR NRF2;

CLINICAL TRIAL; COMPLEX REGIONAL PAIN SYNDROME; ENZYME ACTIVITY; GENE EXPRESSION; GENE FUNCTION; HUMAN; MEDICAL DECISION MAKING; OXIDATIVE STRESS; PROPHYLAXIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ANTIOXIDANTS; COMPLEX REGIONAL PAIN SYNDROMES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME, HUMAN; HUMANS; NF-E2-RELATED FACTOR 2; OXIDATION-REDUCTION; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 76149100903     PISSN: 15333159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. Cho HY, Kleeberger SR. Nrf2 protects against airway disorders. Toxicol Appl Pharmacol 2009; In Press.
2. Hirota K, Nakamura H, Masutani H, Yodoi J. Thioredoxin superfamily and thioredoxin-inducing agents. Ann NY Acad Sci 2002; 957:189-199.
3. Yamamoto M, Yang G, Hong C, Liu J, Holle E, Yu X, Wagner T, Vatner SF, Sadoshima J. Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J Clin Invest 2003; 112:1395-1406.
4. Liu W, Nakamura H, Shioji K, Tanito M, Oka S, Ahsan M.K, Son A, Ishii Y, Kishimoto C, Yodoi J.. Thioredoxin-1 ameliorates myosin-induced autoimmune myocarditis by suppressing chemokine expressions and leukocyte chemotaxis in mice. Circulation 2004; 110:1276-1283.
5. Otterbein LE, Kolls JK, Mantell LL, Cook JL, Alam J, Choi AM. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest 1999; 103:1047-1054.
6. Thompson K, Menzies S, Muckenthaler M, Torti FM, Wood T, Torti SV, Hentze MW, Beard J, Connor J. Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress. J Neurosci Res 2003; 71:46-63.
7. Collins FS, Brooks LD, Chakravarti A. A DNA polymorphism discovery resource for research on human genetic variation. Genome Res 1998; 8:1229-1231.
8. Chorley BN, Wang X, Campbell MR, Pittman GS, Noureddine MA, Bell DA. Discovery and verification of functional single nucleotide polymorphisms in regulatory genomic regions: Current and developing technologies. Mutat Res 2008; 659:147-57.
9. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-Thomann N, Stojanovic N, Subramanian A, Wyman D, Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, Grafham D, Gregory S, Hubbard T, Humphray S, Hunt A, Jones M,. Lloyd C, McMurray A, Matthews L, Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, Ross M, Shownkeen R, Sims S, Waterston RH, Wilson RK, Hillier LW, McPherson JD, Marra MA, Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish WR, Chissoe SL, Wendl MC, Delehaunty KD, Miner TL, Delehaunty A, Kramer JB, Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T, Branscomb E, Predki P, Richardson P, Wenning S, Slezak T, Doggett N, Cheng JF, Olsen A, Lucas S, Elki C, Uberbacher E, Frazie M, Gibbs RA, Muzny DM, Scherer SE, Bouck JB, Sodergren EJ, Worley KC, Rives CM, Gorrell JH, Metzker ML, Naylor SL, Kucherlapati RS, Nelson DL, Weinstock GM, Sakaki Y, Fujiyama A, Hattori M, Yada T, Toyoda A, Itoh T, Kawagoe C, Watanabe H, Totoki Y, Taylor T, Weissenbach J, Heilig R, Saurin W, Artiguenave F, Brottier P, Bruls T, Pelletier E, Robert C, Wincker P, Smith DR, Doucette-Stamm L, Rubenfield, M, Weinstock K, Lee HM, Dubois J, Rosenthal A, Platzer M, Nyakatura G, Taudien S, Rump A, Yang H, Yu J, Wang J, Huang G, Gu J, Hood L, Rowen L, Madan A, Qin S, Davis RW, Federspiel NA, Abola AP, Proctor MJ, Myers RM, Schmutz J, Dickson M, Grimwood J, Cox DR, Olson MV, Kaul R., Shimizu N, Kawasaki K, Minoshima S, Evans GA, Athanasiou M, Schultz R, Roe BA, Chen F, Pan H, Ramser J, Lehrach H., Reinhardt R, McCombie WR, de la Bastide M, Dedhia N, Blocker H, Hornischer K, Nordsiek G, Agarwala R, Aravind L, Bailey JA, Bateman A, Batzoglou S, Birney E, Bork P, Brown DG, Burge CB, Cerutti L, Chen HC, Church D, Clamp M, Copley RR, Doerks T, Eddy SR, Eichler EE, Furey TS, Galagan J, Gilbert JG, Harmon C, Hayashizaki Y, Haussler D, Hermjakob H, Hokamp K, Jang W, Johnson LS, Jones TA, Kasif S, Kaspryzk A, Kennedy S, Kent WJ, Kitts P, Koonin EV, Korf I, Kulp D, Lancet D, Lowe TM, McLysaght A, Mikkelsen T, Moran JV, Mulder N, Pollara VJ, Ponting CP, Schuler G, Schultz J, Slater G, Smit AF, Stupka E, Szustakowski J, Thierry-Mieg D, Thierry-Mieg J, Wagner L, Wallis J, Wheeler R, Williams A, Wolf YI, Wolfe KH, Yang SP, Yeh RF, Collins F, Guyer MS, Peterson J, Felsenfeld A, Wetterstrand KA, Patrinos A, Morgan MJ, de Jong P, Catanese JJ, Osoegawa K, Shizuya H, Choi S, Chen YJ. Initial sequencing and analysis of the human genome. Nature 2001; 409:860-921.
10. I.H.G.S. Consortium, Finishing the euchromatic sequence of the human genome. Nature 2004; 431:931-945.
11. Ponomarenko JV, Orlova GV, Merkulova TI, Gorshkova EV, Fokin ON, Vasiliev GV, Frolov AS, Ponomarenko MP, rSNP-Guide: an integrated database tools system for studying SNPs and site-directed mutations in transcription fac tor binding sites. Hum Mutat 2002; 20:239-248.
12. Wang X, Tomso DJ, Liu X, Bell DA. Single nucleotide polymorphism in transcriptional regulatory regions and expression of environmentally responsive genes. Toxicol Appl Pharmacol 2005; 207:84-90.
13. Wang X, Tomso DJ, Chorley BN, Cho HY, Cheung VG, Kleeberger SR, Bell DA. Identification of polymorphic antioxidant response elements in the human genome. Hum Mol Genet 2007; 16:1188-1200.
14. Knight JC. Functional implications of genetic variation in non-coding DNA for disease susceptibility and gene regulation. Clin Sci (Lond) 2003; 104:493-501.
15. Knight JC. Regulatory polymorphisms underlying complex disease traits. J Mol Med 2005; 83:97-109.
16. Shabalina SA, Zaykin DV, Gris P, Ogurtsov AY, Gauthier J, Shibata K, Tchivileva IE, Belfer I, Mishra B, Kiselycznyk C, Wallace MR, Staud R, Spiridonov NA, Max MB, Goldman D, Fillingim RB, Maixner W, Diatchenko L. Expansion of the human mu-opioid receptor gene architecture: Novel functional variants. Hum Mol Genet 2009; 18:1037-1051.
17. Huang CJ, Liu HF, Su NY, Hsu YW, Yang CH, Chen CC, Tsai PS. Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females. Anaesthesia 2008; 63:1288-1295.
18. Ginosar Y, Davidson EM, Meroz Y, Blotnick S, Shacham M, Caraco Y. Mu-opioid receptor (A118G) single-nucleotide polymorphism affects alfentanil requirements for extracorporeal shock wave lithotripsy: A pharmacokineticpharmacodynamic study. Br J Anaesth 2009; 103:420-427.
19. Walter C, Lötsch J. Meta-analysis of the relevance of the OPRM1 118A→G genetic variant for pain treatment. Pain 2009; 146:270-275.
20. Campbell CM, Edwards RR, Carmona C, Uhart M, Wand G, Carteret A, Kim YK, Frost J, Campbell JN. Polymorphisms in the GTP cyclohydrolase gene (GCH1) are associated with ratings of capsaicin pain. Pain 2009; 141:114-118.
21. Tegeder I, Costigan M, Griffin RS, Abele A, Belfer I, Schmidt H, Ehnert C, Nejim J, Marian C, Scholz J, Wu T, Allchorne A, Diatchenko L, Binshtok AM, Goldman D, Adolph J, Sama S, Atlas SJ, Carlezon WA, Parsegian A, Lötsch J, Fillingim RB, Maixner W, Geisslinger G, Max MB, Woolf CJ. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med 2006; 12:1269-1277.
22. Tegeder I, Adolph J, Schmidt H, Woolf CJ, Geisslinger G, Lotsch J. Reduced hyperalgesia in homozygous carriers of a GTP cyclohydrolase 1 haplotype. Eur J Pain 2008; 12:1069-1077.
23. Kim H, Dionne RA. Lack of influence of GTP cyclohydrolase gene (GCH1) variations on pain sensitivity in humans. Mol Pain 2007; 3:6.
24. Diatchenko L, Nackley AG, Slade GD, Bhalang K, Belfer I, Max MB, Goldman D, Maixner W. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2006; 125:216-224.
25. Treister R, Pud D, Ebstein RP, Laiba E, Gershon E, Haddad M, Eisenberg E. Associations between polymorphisms in dopamine neurotransmitter pathway genes and pain response in healthy humans. Pain 2009; 147:187-193.
26. Ono S, Ezura Y, Emi M, Fujita Y, Takada D, Sato K, Ishigami T, Umemura S, Takahashi K, Kamimura K, Bujo H, Saito Y. A promoter SNP (-1323T→C) in Gsubstrate gene (GSBS) correlates with hypercholesterolemia. J Hum Genet 2003; 48:447-450.
27. Sugatani J, Yamakawa K, Yoshinari K, Machida T, Takagi H, Mori M, Kakizaki S, Sueyoshi T, Negishi M, Miwa M. Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia. Biochem Biophys Res Commun 2002; 292:492-497.
28. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, Lindhout D, Tytgat GNJ, Jansen PLM, Elferink RPJO, Chowdhury NR. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 1995; 333:1171-1175.
29. Nakamura S, Kugiyama K, Sugiyama S, Miyamoto S, Koide S, Fukushima H, Honda O, Yoshimura M, Ogawa H. Polymorphism in the 50-flanking region of human glutamate-cysteine ligase modifier subunit gene is associated with myocardial infarction. Circulation 2002; 105:2968-2973.
30. Marzec JM, Christie JD, Reddy SP, Jedlicka AE, Vuong H, Lanken PN, Aplenc R, Yamamoto T, Yamamoto M, Cho HY, Kleeberger SR. Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury. FASEB J 2007; 21:2237-2246.
31. Jinnai N, Sakagami T, Sekigawa T, Kakihara M, Nakajima T, Yoshida K, Goto S, Hasegawa T, Koshino T, Hasegawa Y, Inoue H, Suzuki N, Sano Y, Inoue I. Polymorphisms in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach. Hum Mol Genet 2004; 13:3203-3217.
32. Boas R. Complex regional pain syndromes: Symptoms, signs and differential diagnosis. In Janig W, Stanton-Hicks M (eds). Reflex Sympathetic Dystrophy: A Reappraisal. IASP Press, Seattle, 1996, pp 79-92.
33. Stanton-Hicks M, Janig W, Hassenbusch S, Haddox JD, Boas R, Wilson P. Reflex sympathetic dystrophy: Changing concepts and taxonomy. Pain 1995; 63:127-133.
34. Merskey H, Bogduk N. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. IASP Press, Seattle: 1994.
35. Harden RN, Bruehl S, Stanton-Hicks M, Wilson PR. Proposed new diagnostic criteria for complex regional pain syndrome. Pain Med 2007; 8:326-331.
36. Harden RN, Bruehl S, Galer B, Saltz S, Bertram M, Backonja M, Gayles R, Rudin N, Bhugra MK, Stanton-Hicks M. Complex regional pain syndrome: Are the IASP diagnostic criteria valid and sufficiently comprehensive? Pain 1999; 83:211-219.
37. Xanthos D, Francis L, Bennett G, Coderre T. Animal models of chronic pain: chronic post-ischemia pain: A novel animal model of complex regional pain syndrome type 1 produced by prolonged hindpaw ischemia and reperfusion in the rat. J Pain 2004; 5: S1.
38. Zuurmond WW, Langendijk PN, Bezemer PD, Brink HE, de Lange JJ, van Ioenen AC. Treatment of acute reflex sympathetic dystrophy with DMSO 50% in a fatty cream. Acta Anaethesiol Scand 1996; 40:364-367.
39. Coderre TJ, Xanthos DN, Francis L, Bennett GJ. Chronis post-ischemia pain (CPIP): A novel animal model of com plex regional pain syndrome-type 1 (CRPS-1; reflex sympathetic dsytrophy) produced by prolonged hindpaw ischemia and reperfusion in the rat. Pain 2004; 112:94-105.
40. Ludwig J, Gorodetskaya N, Schattschneider J, Jänig W, Baron R. Behavioral and sensory changes after direct ischemia-reperfusion injury in rats. Eur J Pain 2007; 11: 677-684.
41. Zollinger PD, Tuinebreijer WE, Breederveld RS, Kreis RW. Can vitamin c prevent complex regional pain syndrome in patients with wrist fractures? A randomized, controlled, multicenter dose-response study. J Bone Joint Surg Am 2007; 89: 1424-1431.
42. Eisenberg E, Shtahl S, Geller R, Reznick AZ, Sharf O, Ravbinovich M, Erenreich A, Nagler RM. Serum and salivary oxidative analysis in Complex Regional Pain Syndrome. Pain 2008; 138:226-232.
43. Groeneweg JG, Huygen FJ, Heijmans-Antonissen C, Niehof S, Zijlstra FJ. Increased endothelin-1 and diminished nitric oxide levels in blister fluids of patients with intermediate cold type complex regional pain syndrome type 1. BMC Musculoskelet Disord 2006; 7:91-98.
44. Van der Laan L, Kapitein PJC, Oyen WJG, Verhofstad AAJ, Hendriks T, Goris RJA. A novel animal model to evaluate oxygen derived free radical damage in soft tissue. Free Radic Res 1997; 26:363-372.
45. Yonehara N, Yoshimura M. Effect of nitric oxide on substance P release from the peripheral endings of primary afferent neurons. Neurosci Lett 1999; 271:199-201.
46. Geertzen JHB, de Bruijn H, de Bruijn-Kofman AT, Arendzen JH. Reflex sympathetic dystrophy: Early treatment and psychological aspects. Arch Phys Med Rehabil 1994; 75:442-446.
47. Goris RJA, Dongen LMV, Winters HAH. Are toxic oxygen radicals involved in the pathogenesis of reflex sympathetic dystrophy? Free Radic Res Commun 1987; 3:13-21.
48. Perez RS, Zuurmond WW, Bezemer PD, Kuik DJ, van Loenen AC, de Lange JJ, Zuidhof AJ. The treatment of complex regional pain syndrome type I with free radical scavengers: A randomized controlled study. Pain 2003; 102:297-307.
49. Zollinger PE, Tuinebreijer WE, Kreis RW, Breederveld RS. Effect of vitamin C on frequency of reflex sympathetic dystrophy in wrist fractures: a randomized trial. Lancet 1999; 345:2025-2028.
50. Zyluk A. The reasons for poor response to treatment of posttraumatic reflex sympathetic dystrophy. Acta Orthop Belg 1998; 64:309-313.
51. Coderre TJ, Bennett GJ. Objectifying CRPS-I. Pain 2008; 138:3-4.
52. Laferrière A, Xanthos DN, Coderre TJ. Short-term exercise increases hind paw muscle lactic acid and allodynia in rats with chronic post-ischemia pain. Poster presentation, IASP 12th World Congress on Pain, Glasgow, UK, August 17-23, 2008.
53. Xanthos DN, Coderre TJ. Sympathetic vasoconstrictor antagonism and vasodilatation relieve mechanical allodynia in rats with chronic postischemia pain. J Pain 2008; 9:423-433.
54. Xanthos DN, Bennett GJ, Coderre TJ. Norepinephrine-induced nociception and vasoconstrictor hypersensitivity in rats with chronic post-ischemia pain. Pain 2008; 137:640-651.
55. Kumar R, Aggarwal A, Faridi MM. Complex regional pain syndrome type 1 and scurvy. Indian Pediatr 2009; 46:529-531.
56. Zollinger PE, Ellis ML, Unal H, Tuinebreijer WE. Clinical outcome of cementless semi-constrained trapeziometacarpal arthroplasty, and possible effect of vitamin C on the occurrence of complex regional pain syndrome. Acta Orthop Belg 2008; 74:317-322.
57. Besse JL, Gadeyne S, Galand-Desmé S, Lerat JL, Moyen B. Effect of vitamin C on prevention of complex regional pain syndrome type I in foot and ankle surgery. Foot Ankle Surg 2009; 15:179-182.
58. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama M, Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Commun 1997; 236:313-322.
59. Itoh K, Wkabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Develop 1999; 13:76-86.
60. Itoh K, Tong KI, Yamamoto M. Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol 2004; 36:1208-1213.
61. Jeyapaul J, Jaiswal AK. Nrf2 and c-Jun regulation of antioxidant response element (ARE)-mediated expression and induction of gamma-glutamylcysteine synthetase heavy subunit gene. Biochem Pharmacol 2000; 59:1433-1439.
62. He CH, Gong P, Hu B, Stewart D, Choi ME, Choi AM, Alam J. Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation. J Biol Chem 2001; 276:20858-20865.
63. Venugopal R, Jaiswal AK. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc Natl Acad Sci USA 1996; 93:14960-14965.
64. Zhu M, Fahl WE. Functional characterization of transcription regulators that interact with the electrophile response element. Biochem Biophys Res Commun 2001; 289:212-219.
65. Katsuoka F, Motohashi H, Ishii T, Aburatani H, Engel JD, Yamamoto M. Genetic evidence that small maf proteins are essential for the activation of antioxidant response element-dependent genes. Mol Cell Biol 2005; 25:8044-8051.
66. Katsuoka F, Motohashi H, Engel JD, Yamamoto M. Nrf2 transcriptionally activates the mafG gene through an antioxidant response element. J Biol Chem 2005; 280:4483-4490.
67. Itoh K, Igarashi K, Hayashi N, Nishizawa M, Yamamoto M. Cloning and characterization of a novel erythroid cellderived CNC family transcription factor heterodimerizing with the small Maf family proteins. Mol Cell Biol 1995; 15:4184-4193.
68. Cho HY, Reddy SP, DeBiase A, Yamamoto M, Kleeberger SR. () Gene expression profiling of NRF2-mediated protection against oxidative injury. Free Radic Biol Med 2005; 38:325-343.
69. Marzec JM, Christie JD, Reddy SP, Jedlicka AE, Vuong H, Lanken PN, Aplenc R, T, Yamamoto M, Cho H-Y, Kleeberger SR. Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury. The FASBE J 2007; 21:2237-2246.
70. Kaspar JW, Jaiswal AK. Antioxidant Induced Phosphorylation of Tyrosine486 leads to rapid nuclear export of bach1 that allows Nrf2 to bind to the ARE and Activate defensive genes expression J Biol Chem 2009; In Press.
71. Igarashi K, Hoshino H, Muto A, Suwabe N, Nishikawa S, Nakauchi H, Yamamoto M. Multivalent DNA binding complex generated by small Maf and Bach1 as a possible biochemical basis for betaglobin locus control region complex. J Biol Chem 1998; 273:11783-11790.
72. Dhakshinamoorthy S, Jain AK, Bloom DA, Jaiswal AK. J Biol Chem 2005; 280:16891-16900.
73. Oyake T, Itoh K, Motohashi H, Hayashi N, Hoshino H, Nishizawa M, Yamamoto M, Igarashi K. Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol Cell Biol 1996; 16:6083-6095.
74. Sun J, Hoshino H, Takaku K, Nakajima O, Muto A, Suzuki H, Tashiro S, Takahashi S, Shibahara S, Alam J, Taketo MM, Yamamoto M, Igarashi K. EMBO J 2002; 21:5216-5224.
75. Singh A, Rangasamy T, Thimmulappa RK, Lee H, Osburn WO, Brigelius-Flohé R, Kensler TW, Yamamoto M, Biswal S. Cell Mol Biol 2006; 35:639-650.
76. Sun J, Brand M, Zenke Y, Tashiro S, Groudine M, Igarashi K. Proc Natl Acad Sci USA 2004; 101:1461-1466.
77. Kwak MK, Itoh K, Yamamoto M, Kensler TW. Enhanced expression of the transcription factor Nrf2 by cancer chemopreventive agents: role of antioxidant response element like sequences in the nrf2 promoter. Mol Cell Biol 2002; 22:2883-2892.
78. Yamamoto T, Yoh K, Kobayashi A, Ishii Y, Kure S, Koyama A, Sakamoto T, Sekizawa K, Motohashi H, Yamamoto M. Identification of polymorphisms in the promoter region of the human NRF2 gene. Biochem Biophys Res Commun 2004; 321:72-79.
79. Alam J, Stewart D, Touchard C, Boinapally S, Choi AM, Cook JL. Nrf2, a cap'n'collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem 1999; 274:26071-26078.
80. Chan K, Lu R, Chang JC, Kan YW. Nrf2, a member of NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth and development. Proc Natl Acad Sci USA 1999; 93:13943-13948.
81. Venugopal R, Jaiswal AK. Nrf2 and Nrf1 in association with Jun proteins regulate the antioxidant response elementmediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene 1998; 17:3145-3156.
82. Cho H, Reddy SPM, Yamamoto M, Kleeberger SR. The transcription factor NRF2 protects against pulmonary fibrosis. FASEB J 2004; 18:1258-1260.
83. Ramos-Gomez M, Kwak MK, Dolan PM, Itoh K, Yamamoto M, Talalay P, Kensler TW. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci USA 2001; 98:3410-3415.
84. Chan K, Kan YW. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc Natl Acad Sci USA 1999; 96;12731-1273.
85. Chowdry S, Nazmy MH, Meakin PJ, Dinkova-Kostova AT, Walsh SV, Tsujita T, Dillon JF, Ashford ML, Hayes JD. Loss of Nrf2 markedly exacerbates non-alcoholic steatohepatitis. Free Radic Biol Med 2009; In Press.
86. Reddy AJ, Christie JD, Aplenc R, Fuchs B, Lanken PN, Kleeberger SR. Association of human NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Polymorphism with development of acute lung injury. J Cell Mol Med 2008; In Press.
87. de Mos M, Laferrière A, Millecamps M, Pilkington M, Sturkenboom MC, Huygen FJ, Coderre TJ. Role of NFkappaB in an animal model of complex regional pain syndrome-type I (CRPS-I). J Pain 2009;10:1161-1169.
88. Reuben SS, Rosenthal EA, Steinberg RB. Surgery on the affected upper extremity of patients with a history of complex regional pain syndrome: Aa retrospective study of 100 patients. J Hand Surg Am 2000; 25:1147-1151.